Guardant Health, Inc.
GH
$18.82
-$0.28-1.47%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 155.05M | 143.03M | 137.15M | 128.71M | 126.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 155.05M | 143.03M | 137.15M | 128.71M | 126.89M |
| Cost of Revenue | 62.52M | 57.61M | 53.85M | 53.07M | 47.12M |
| Gross Profit | 92.54M | 85.42M | 83.30M | 75.64M | 79.77M |
| SG&A Expenses | 117.02M | 105.11M | 112.56M | 116.87M | 123.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.90M | 256.07M | 256.27M | 262.47M | 274.71M |
| Operating Income | -113.84M | -113.04M | -119.12M | -133.76M | -147.81M |
| Income Before Tax | -187.58M | -85.61M | -72.28M | -133.29M | -139.33M |
| Income Tax Expenses | -541.00K | 490.00K | 496.00K | 240.00K | 602.00K |
| Earnings from Continuing Operations | -187.04M | -86.10M | -72.77M | -133.53M | -139.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -187.04M | -86.10M | -72.77M | -133.53M | -139.93M |
| EBIT | -113.84M | -113.04M | -119.12M | -133.76M | -147.81M |
| EBITDA | -102.97M | -102.01M | -108.49M | -123.41M | -137.65M |
| EPS Basic | -1.58 | -0.73 | -0.67 | -1.30 | -1.37 |
| Normalized Basic EPS | -0.52 | -0.54 | -0.41 | -0.80 | -0.89 |
| EPS Diluted | -1.58 | -0.73 | -0.67 | -1.30 | -1.37 |
| Normalized Diluted EPS | -0.52 | -0.54 | -0.41 | -0.80 | -0.89 |
| Average Basic Shares Outstanding | 118.51M | 117.74M | 108.81M | 102.66M | 102.52M |
| Average Diluted Shares Outstanding | 118.51M | 117.74M | 108.81M | 102.66M | 102.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
